electroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Migraine
10 janv. 2022 16h01 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper,...
electroCore to Present at H.C. Wainwright BIOCONNECT Virtual Conference
04 janv. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Jan. 04, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
electroCore, Inc. Provides Update on Global Distribution Partners
16 déc. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 16, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced it has entered into agreements...
electroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom
15 déc. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 15, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced the launch of an e-commerce...
electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder
14 déc. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today provided an update on the ongoing...
electroCore Announces New Patent for Stroke and TIA Treatment
13 déc. 2021 08h55 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 13, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent...
electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
11 nov. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Nov. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be...
electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
21 oct. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third...
electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England
20 oct. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper entitled...
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
19 oct. 2021 10h03 HE
|
Odyssey Group International
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving...